Next Article in Journal
Expanding the Horizons of CAR-T Cell Therapy: A Review of Therapeutic Targets Across Diverse Diseases
Previous Article in Journal
Potential Applications of Rare Earth Metal Nanoparticles in Biomedicine
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Lebanese Medicinal Plants with Ophthalmic Properties

by
Jeanne Andary
1,2,*,
Haitham El Ballouz
2 and
Rony Abou-Khalil
3
1
Faculty of Health Sciences, Modern University for Business and Science, Beirut P.O. Box 113-7501, Lebanon
2
Department of Optics and Optometry, Faculty of Health Sciences, American University of Science and Technology, Beirut P.O. Box 16-6452, Lebanon
3
Biology Department, Faculty of Arts and Sciences, Holy Spirit University of Kaslik, Jounieh P.O. Box 446, Lebanon
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2025, 18(2), 155; https://doi.org/10.3390/ph18020155
Submission received: 1 December 2024 / Revised: 13 January 2025 / Accepted: 19 January 2025 / Published: 24 January 2025
(This article belongs to the Section Natural Products)

Abstract

:
Lebanon benefits from a rich biodiversity, with medicinal and aromatic plants (MAPs) representing an important part of the country’s natural wealth; however, limited data are available documenting medicinal plants being employed in eye health. This review is the first to document Lebanese medicinal plants with ophthalmic characteristics and phytochemistry that might be beneficial in the development of new, accessible, and efficient ocular medications. In this study, we searched for studies on ocular therapeutic plants using known resources, including PubMed, ScienceDirect, and Google Scholar, and confirmed these plants’ presence within the Lebanese flora. The efficacy of 52 species from 28 families, including two endemic species (Crepis libanotica and Salvia libanotica), has been documented. Their Latin names, regional names, ocular medical applications, the plant parts used, and preparation forms are detailed below. The largest number of species belongs to the Lamiaceae family (21%), followed by Asteraceae (14%) and Solanaceae (7%). The most commonly used plant parts are the stems, leaves, and seeds. Ocular treatments fall into several categories: inflammation, infection, irritation, dry-eye, eyewash, the prevention or delay of cataracts, and general eye problems. A significant percentage (68%) of the medicinal plants target the anterior part of the eye. Some of the reported plants can be harmful to the eyes and should be handled with caution. The Lebanese medicinal plants listed, constituting a local heritage with global importance, could be used for treating ophthalmic ailments and require special screening and preservation.

1. Introduction

For centuries, herbal medicine has been used to treat a wide range of human disorders, with at least 80% of the world’s population, primarily in developing countries, relying on it for primary healthcare [1]. Since the beginning of civilization, humans have used resources from fauna and flora to treat eye diseases [2]. Pharmacologically active preparations that modulate eye activity have been utilized for over 2000 years, with Atropa belladonna extracts originally being used for pupillary dilatation [3]. Owing to their low cost, herbal medicines are increasingly preferred over contemporary pharmaceuticals, and conservative remedies are still popular for use in reversible ailments.
The Mediterranean Basin, with its mild climate and millennia-old population, is rich in plant diversity, including rare and endemic plants [4]. The daily Mediterranean diet includes vegetables, fruits, and spices, with both cultivated and wild food species providing essential nutritional value and medicinal properties [5]. Lebanon, located on the eastern shore of the Mediterranean Sea, benefits from a rich biodiversity [6], hosting more than 4500 plant species, 2863 of which are considered native, and an endemism rate of 12% [7]. A range of conventional herbal eye drops made from a variety of medicinal plants can be used to treat ocular diseases [2]. The development and exploration of a country’s untapped medical knowledge is necessary for the better management of ocular disorders. Therefore, documenting and categorizing the nation’s currently unknown medical information is crucial in improving the management of eye illnesses.
The purpose of this study was to highlight, for the first time, numerous Lebanese medicinal plants that have been traditionally used to treat eye disorders, which could be further researched for use in various ocular diseases. It is the right of the local population to better understand, use, and develop their indigenous resources. Additionally, this study can serve as a valuable starting point for researchers to develop new and more effective ocular formulations that respect plant biodiversity and environmental sustainability.

2. Major Ocular Diseases

The eye is a paired organ located in the orbital cavity, responsible for capturing images transmitted to the cortical vision center [8]. The anterior segment of the eye includes ocular structures from the anterior part of the cornea to the posterior part of the lens, as well as the trabecular meshwork (TM) and aqueous humor [9] (Figure 1). Posterior-segment eye disease (PSED) is commonly defined as comprising diseases of the retina, choroid, and optic nerve and primarily includes glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR) [10]. Ocular diseases affect vision and can lead to irreversible blindness and the loss of visual acuity. However, many causes of vision impairment can be prevented or treated [11].
At least 2.2 billion people worldwide suffer from visual impairment, with at least one billion having conditions that could have been avoided or remain untreated. The World Health Organization estimates that eye conditions are disproportionately more prevalent in low- and middle-income countries and medically underserved populations. It is also estimated that 11.9 million people globally suffer from moderate or severe vision impairment or blindness due to glaucoma, diabetic retinopathy, and trachoma conditions that could have been prevented [12].
Figure 1. Anatomy of the eye with the anterior and posterior segments, created using Biorender.com [13].
Figure 1. Anatomy of the eye with the anterior and posterior segments, created using Biorender.com [13].
Pharmaceuticals 18 00155 g001

2.1. Eye Infections

The eye is one of the most sensitive organs and is constantly exposed to various environmental agents. Tears contain several substances that help protect against infection, while the eyelids and eyelashes shield the ocular surface from the environment and help keep the surface of the eye moist. Occasionally, these defense mechanisms can be disrupted, leading to ocular problems [14]. Due to continuous exposure to the external environment, the eyes are susceptible to infections caused by bacteria, fungi, parasites, or viruses. The range of conditions and diseases that affect the eye vary widely, from redness to loss of vision. Most of these infections present clinically as infections of the anterior segment that include blepharitis, styes, conjunctivitis, corneal ulcers, and keratitis; infections of the lacrimal system, such as canaliculitis and dacryocystitis; or more severe infections affecting the orbit and the posterior segment, like orbital cellulitis and endophthalmitis [15].

2.2. Cataracts, Dry-Eye, and Allergies

Cataracts are the leading cause of visual impairment worldwide and are defined by the presence of lens opacities or the loss of transparency [16]. Cataracts resulting from long-term light exposure are caused by photo-oxidation that decomposes the biological components of the lens, primarily crystallin. The oxidized thiol groups in crystalline molecules form disulfide bonds, leading to crystalline aggregation and cataract formation [17].
The term ‘allergic conjunctivitis’ refers to a group of hypersensitivity disorders that affect the eyelid, conjunctiva, and/or cornea. The primary goal in managing ocular allergies is to identify the causes and prevent recurrence by eliminating them [18].
The Tear Film and Ocular Surface Society Dry Eye Workshop II (TFOS DEWS II) defines dry-eye disease as follows: In addition to causing cytotoxic effects and retinal ganglion cell loss, oxidative stress damages the trabecular meshwork, obstructing the outflow of aqueous humor and raising the intraocular pressure [19].

2.3. Glaucoma, Eye Cancer, and Diabetic Retinopathy

Glaucoma causes a progressive, irreversible loss in retinal ganglion cells, damage to the optic nerve, and loss of vision, both with and without increased intraocular pressure. However, intraocular pressure remains the most important modifiable risk factor. Oxidative stress has cytotoxic effects and causes, leading to retinal ganglion cell death and damage to the trabecular meshwork, which obstructs the outflow of aqueous humor and results in elevated intraocular pressure [20].
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus (DM) and a leading cause of visual loss in working-age populations. Inflammation and retinal neurodegeneration may be involved in DR as independent pathogenesis pathways. The development of agents targeting molecules in these pathways may provide new therapeutic treatments for DR [21].
Eye cancer is a rare disease, with a lower occurrence compared to other forms of cancer, and it is generally less invasive. It can affect either the outer parts of the eye (extraocular cancer) or the eyeball itself (intraocular cancer). In adults, the most common intraocular cancers are melanoma and lymphoma, while in children, retinoblastoma is the most common and may be extraocular or intraocular [22].

3. Methodology

Data collection was carried out through an extensive review of the literature. We initially searched for studies on ocular therapeutic plants in well-known resources, using specific keywords such as medicinal plants, ocular diseases, and ophthalmic plants.
Population (P): This study included published articles (original research) related to medicinal plants used to treat ophthalmic disorders covering the period from January 2000 to October 2024 in English. Articles from PubMed (National Library of Medicine) (188 articles), Science Direct Scopus (146 articles), Google Scholar (41 articles), and published books were used to create a primary list of ophthalmic plants, as well as World Flora Online (http://www.worldfloraonline.org, accessed on 10 October 2024) and Plants of the World Online (https://powo.science.kew.org/, accessed on 10 October 2024). The primary list contained the names of nearly 375 medicinal plants. These plants were then checked for their presence in Lebanese flora using the following resources: http://www.lebanon-flora.org/ accessed on 10 October 2024, and the atlas Nouvelle Flore du Liban et de la Syrie documenting the biodiversity in these regions [23]. Figure 2 illustrates the different steps involved in the study design.
Inclusion criteria: All original research articles on medicinal plants used to treat different ocular disorders in English and related to plants growing in Lebanon.
Exclusion criteria: All data published outside the timeframe of the study period, studies published in languages other than English, or works on plants not native to the Lebanese flora.
The final dataset, consisting of 52 different species, was compiled in an Excel worksheet (Table 1) and arranged alphabetically. The chemical structures were drawn using ChemDraw Professional 15 software.

4. Findings and Discussion

The compiled papers are from a variety of sources: reviews account for 32%, ethnopharmacological surveys for 8%, reports for 8%, and case studies for 3%. Notably, 45% are classified as original research publications (Figure 3); 18% of these articles focused on the eye in vivo, while 15% of the studies were in vitro. In contrast, 12% of the research did not involve either in vitro or in vivo trials.
The names of the medicinal plants found in the Lebanese flora are listed in Table 1, along with their Latin names, regional names, plant parts used, preparation forms, ocular uses, and related sites of action. The plant names were verified using http://www.theplantlist.org, accessed on 10 October 2024. The various plant characteristics were recorded exactly as provided by the reference sources, without any commentary, to prevent misunderstandings or incorrect interpretations. These species are listed in the order of their appearance in the table: Althaea officinalis, Alhagi maurorum, Allium sativum, Anagallis arvensis, Arbutus unedo, Bidens pilosa, Borago officinalis, Capparis spinose, Centaurea cyanus, Chenopodium opulifolium, Cichorioum intybus, Citrullus colocynthis, Crepis robertioides, Crepis libanotica, Cyperus rotundus, Datura stramonium, Daucus carota, Euphrasia officinalis, Ficus carica, Foeniculum vulgare, Fumaria officinalis, Hyoscyamus niger, Iris germanica, Juniperus excelsa, Linum usitatissimum, Ocimum basilicum, Olea europaea, Origanum syriacum, Origanum laevigatum, Malvae sylvestris, Matricaria chamomilla, Marrubium vulgare, Melissa officinalis, Mentha longifolia, Mentha spicata, Nerium oleander, Plantago lanceolate, Portulaca oleracea, Rosa damascena, Rosa centifolia, Rosemarinus officinalis, Salvia sclarea, Salvia Libanotica fruticose, Salvia officinalis, Silybum marianum, Solanum dulcamara, Solanum villosum, Thymus vulgaris, Urginea maritima, Xanthium strumarium, Ziziphus jujube, and Ziziphus spina-christi.

4.1. Family Classification

The effectiveness of 52 species from 28 families, including two indigenous ones (Crepis libanotica and Salvia libanotica), was documented in this study. The majority of species are from the Lamiaceae family (21%), followed by the Asteraceae (14%) and Solanaceae (7%), while Malvaceae, Rhamnaceae, and Rosaceae are present (3% each). Other families accounted for 49% of the total (Figure 4).
Table 1 shows that most of the cited Lebanese medicinal plants have multiple ocular properties. Additionally, many plant families exhibit similar treatment characteristics. Interestingly, the etiology of most ocular diseases involves free radical-mediated oxidative damage, hypoxia, reduced blood supply to ocular tissues, and, in certain conditions, angiogenesis [93]. Phytochemicals show antioxidant, anti-angiogenic, and/or anti-inflammatory activities, and they can also reduce fluid retention and strengthen capillary walls [94]. Therefore, the prevention or treatment of eye disorders may benefit from the selection of these phytochemicals.
To minimize high heterogeneity and traditional publication bias, Table 2 lists the various phytoconstituents found in the listed Lebanese medicinal plants (from research articles only) along with their corresponding mechanisms of action.
Species of the Lamiaceae family have traditionally been used for their curative and preventive properties. Their value stems from the synthesis of a wide range of secondary metabolites with antibacterial, antioxidant, anti-inflammatory, antimicrobial, antiviral, and anticancer properties. The main classes of phenolic compounds identified are phenolic acids, mainly caffeic and rosmarinic acids, and flavonoids. These antioxidant defenses contribute to eye health and maintenance [118]. In this context, the essential oils of Rosemarinus officinalis, Salvia sclarea, and Thymus vulgaris, which contain monoterpene, diterpene, and sesquiterpene hydrocarbons, azulene, alcohols, aldehydes, and ketones, have been cited for their antibacterial properties (Table 2) [80,81,82]. Keratitis caused by the fungus Fusarium can be treated with Salvia sclarea, while amoebic keratitis can be treated with ethanol extracts of Origanum syriacum and Origanum laevigatum [65]. Other beneficial features of this family include its ability to reduce ocular inflammation, as demonstrated by Marrubium vulgare [68], Salvia libanotica fruticose [83], and Salvia officinalis [84].
Long-term exposure to UV, visible ionizing radiation, and environmental toxins cause oxidative damage in ocular tissues, leading to pathological consequences in the ageing eye. While eye tissues, like the tear film, have strong antioxidant defenses against free radicals, the trabecular meshwork lacks these defenses [111]. The inclusion of saturated fatty acids (palmitic and stearic acids) and unsaturated fatty acids (α-linolenic, linoleic, and oleic acids) in Ocimum basilicum has beneficial effects. Moreover, polyunsaturated fatty acids can reduce intraocular pressure due to their anti-inflammatory and antioxidant properties. The contributions of flavonoids (quercetin, rhamnocitrin, and luteolin), phenolic acids (rosmarinic and caffeic), and volatile compounds (geranial, neral, citronellal, and geraniol) explain why Melissa officinalis shows potential in preventing age-related macular degeneration [27,28]. The antimicrobial activity of Thymus vulgaris is attributed to compounds such as α-thujene, α-pinene, and camphene. The essential oil of T. vulgaris can inhibit the growth of microscopic filamentous fungi from the genus Penicillium [116,117]. In addition, polyphenolic extracts from Spearmint (Mentha spicata) may provide nutritional support for neuronal tissues, potentially complementing hypotensive treatments for glaucoma and other ocular conditions by disrupting antioxidant, anti-inflammatory, and neuroprotective mechanisms [72].
The pharmacological effects of Asteraceae plants can be attributed to their wide range of phytochemical compounds, including polyphenols, phenolic acids, flavonoids, acetylenes, and triterpenes. The Asteraceae family exhibits potent antioxidant, anti-inflammatory, and antibacterial properties [119]. Notable species in this category include Bidens pilosa, Centaurea cyanus, Cichorioum intybus, and Matricaria chamomilla, which can be used to alleviate eye inflammation. Crepis robertioides and Crepis libanotica have been used to treat eye infections, while Centaurea cyanus is effective specifically in eyelid and conjunctival inflammation such as blepharitis and conjunctivitis. However, the antioxidant properties of silibinin, a flavonolignan extracted from Silybum marianum, make it useful in the treatment of age-related macular degeneration [86,115]. Many eye conditions are treated with Matricaria chamomilla [30,31]. Additionally, Xanthium strumarium has the potential to enhance vision [90].
The abundance of phytochemicals in the family Solanaceae highlights their potential as healing plants. This family, also known as the nightshade family, includes plants that contain lethal alkaloids [120]. In addition to being an insecticide used to remove Lucilia sericata, Hyoscyamus niger can cause red eyes or itching [57]. Joo, 2023, highlighted the dual role of alkaloids as both therapeutic agents and potential toxins [121]. On the other hand, Solanum dulcamara and Solanum villosum can be used to treat eye inflammation and sore eyes, respectively.
Species of the Malvaceae family possess a wide variety of chemical constituents, such as polysaccharides, coumarins, flavonoids, polyphenols, vitamins, terpenes, and tannins, are found in different plant organs, particularly in the leaves and flowers. These compounds are linked to their biological activity [122]. Althaea officinalis and Malvae sylvestris are notably known for their ability to moisturize the eyes and prevent dry-eye disease. This effect is attributed to the presence of mucilaginous molecules, which may enhance the lubricating effect [35,36].
The health benefits of the Rosaceae family are linked to its secondary metabolites, with enriched extracts finding applications in pharmacology. Its main constituents include flavonoids, triterpenes, tannins, polysaccharides, phenolic acids, fatty acids, organic acids, carotenoids, and vitamins [123]. The flower extracts of Rosa damascena and Rosa centifolia are used for eye washing and treating eye inflammation. Terpenoids and saponins, which are abundant in the genus Ziziphus, are responsible for many of its health benefits [124]. Rhamnaceae plants Ziziphus jujube and Ziziphus spina-christi have also been utilized to treat eye inflammation.

4.2. Plant Parts

Most plant components are applied topically to the affected area of the eye and utilized externally, although some are also used internally. The stem was prevalent in the remedies that we found (17%), followed by aerial parts (15%), leaves (4%), and flowers (8%) (Figure 5).

4.3. Ocular Preparation and Administration

The 52 medicinal plants cited in this study were prepared and administered using a variety of techniques, as shown in Table 1. These methods are accurately reported as cited in the references. Infusion, decoction, or maceration in water are the basic methods used to obtain aqueous plant extracts. A decoction is typically used for the harder or woodier parts of the plant; it involves placing the plant in cold water, roughly divided, and boiling the mixture for at least 15 min over a moderate flame [125]. Anagallis arvensis leaf juice can be used to improve eyesight, while an infusion of Borago officinalis leaves can treat conjunctivitis. Both the flower of Fumaria officinalis and the rhizome decoction of Cyperus rotundus can be used as alternative remedies for conjunctivitis. Eyebright, also known as Euphrasia officinalis, has historically been used in folk medicine mostly to treat eye conditions.
Additionally, solvents can penetrate plant cell walls to release intracellular compounds, thereby increasing the yield of the extracts. Studies have shown that using alcohol-based solvents, especially in aqueous mixtures (e.g., 80% methanol or ethanol), can improve the extraction of phenolic content and antioxidant activities [126]. It has been suggested that the methanolic extracts of Citrullus colocynthis, Allium sativum, and Iris germanica could delay the development of cataracts, reduce intraocular pressure, and treat conjunctivitis. Additionally, methanolic extracts of Origanum basilicum and Origanum syriacum have been linked to the treatment of amoebic keratitis.
Essential oils (EOs) are complex mixtures of secondary metabolites with specific chemical compositions that vary according to the plant’s characteristics. In the East, aromatic substances are often considered more than just perfumes and are used for therapeutic purposes [81]. The essential oils of Thymus vulgaris, Salvia sclarea, Rosemarinus officinalis, and Salvia officinalis have also been cited for their numerous ocular qualities, particularly their antibacterial effects.
Some formulations were cited in specific forms, such as lotions (Plantago lanceolate and Fumaria officinalis) and ointments (Chenopodium opulifolium and Olea europaea). When blended with sugar, Alhagi maurorum flower powder is used to cleanse the eye and improve vision. Linum usitatissimum oil capsules have been used to treat patients with dry-eye and Sjögren’s syndrome. The simple edible plants mentioned include Arbutus unedo, Daucus carota, Foeniculum vulgare, and Portulaca oleracea.

4.4. Disease Treatment Classification

Recent preclinical studies have explored the use of re-emerging herbal compounds for prophylaxis and management in anterior- and posterior-segment eye diseases [127]. A significant percentage (68%) of the cited Lebanese medicinal plants could be used to target the anterior portion of the eye. The most frequently recommended treatments were for eye infections or inflammation, leading to symptoms such as pain, redness, discharge, excessive moisture, and light sensitivity. These characteristics are commonly observed in species belonging to the Lamiaceae and Asteraceae families, as previously mentioned. Certain plants, such as Bidens pilosa, Linum usitatissimum, Malvae sylvestris, Melissa officinalis, and Olea europaea, have been found to play a role in stabilizing the tear film, thus reducing dry-eye symptoms. Daucus carota, rich in carotenoids such as beta-carotene, lutein, and zeaxanthin, helps protect the eye from oxidative stress, apoptosis, mitochondrial dysfunction, and inflammation. Additionally, Matricaria chamomilla may offer protection against ultraviolet (UV) radiation or cataract development (Table 2). A lower incidence of age-related eye disorders is associated with a high intake of these carotenoids. These phytomolecules are lipophilic, meaning they can penetrate biological barriers like the blood–retina barrier (BRB). As a result, their ability to reach the retina enables them to have anti-inflammatory and antioxidant effects [128].
However, 5% of the listed medicinal plants, including Chenopodium opulifolium, Juniperus excels, and Urginea maritima, are suggested for use in treating unspecified eye disorders.
The complex structure and physiology of the eye make it difficult for ophthalmologists to treat posterior-segment ocular diseases such as age-related macular degeneration (AMD) or diabetic retinopathy (DR) [129]. As illustrated in Figure 6, only 9% of the cited medicinal plants are effective for conditions such as glaucoma or AMD. The specialized nature of the eye includes several static and moving obstacles that prevent drugs from reaching their intended target sites of action. Therefore, new carrier systems for herbal phytoconstituents should be developed to overcome the poor permeability and absorption limitations at the desired site of action [127]. Research indicates that Arbutus unedo can delay or prevent cataracts due to the presence of zeaxanthin [130,131]. Borago officinalis contains gamma-linolenic acid, a vasodilator that improves blood flow and may help lower retinal venous pressure [34]. Melissa officinalis (Lamiaceae) is used for age-related macular degeneration (AMD) due to its volatile compounds (geranial, citronellal, and geraniol), phenolic acids (rosmarinic and caffeic acid), and flavonoids (quercetin, rhamnocitrin, and luteolin). These phytochemicals can reduce apoptosis and oxidative damage while exhibiting potent antioxidant properties, acting as radical scavengers [69,113]. Additionally, phenolic compounds derived from Mentha spicata have been linked to improvements in neurotrophin levels, along with reductions in oxidative stress and inflammation markers, making them beneficial in treating glaucoma [72]. Finally, Silybum marianum is effective in treating age-related macular degeneration (AMD), primarily due to its flavonolignans, which possess antioxidant properties [86,115].
Treating posterior-segment ocular illnesses can be challenging; however, drug permeability improves with increased lipophilicity and decreases with lower molecular weight and/or reduced protein binding [129]. Table 3 lists the main phytochemical components along with their solubility, molecular weight, and functional groups. Plants that target both the anterior and posterior parts simultaneously include Allium sativum [132], Foeniculum vulgare [55], Rosa damascene [133], and Rosemarinus officinalis [134]. For example, solubility affects their capacity to cross ocular barriers, and functional groups determine how they interact with biological targets. Most of the listed molecules are slightly soluble in water but exhibit higher solubility in organic solvents. Additionally, their molecular weight ranges from 148 to 360 Da. Understanding these characteristics aids in the development of efficient ocular drug delivery systems [135].

4.5. Toxicology of Some Cited Medicinal Plants

The common belief that herbal remedies have no side effects has led to the widespread use of traditional eye medications. However, this dangerous misuse can result in ocular morbidity due to close contact with the eyes. Herbal eye “medicines” are believed to cause 8-10% of corneal blindness in Africa [137]. The negative effects include a worsening of the initial condition and an increased risk of infections, which, in extreme cases, can result in total eye injury. Since 11% of the described plants show signs of toxicity, caution should be exercised when handling plants that can harm the eyes, such as Datura stramonium, Ficus carica, Hyoscyamus niger, Nerium oleander, and Urginea maritima. The primary hazardous phytochemicals are listed in Table 4. Alkaloids such as atropine, scopolamine, and hyoscyamine are responsible for blocking the muscarinic acetylcholine receptors in the iris sphincter muscle, preventing contracting [138]. Some documented adverse outcomes include photophobia, mydriasis, blurred vision, and eye pain.
Additionally, the branches, leaves, and fruit skin of the fig tree (Ficus carica) release a milky sap or latex that contains proteolytic enzymes and furocoumarins. These compounds are known to be photoirritants [51].

5. Conclusions

Thousands of medicinal plant species have significant economic, social, and ecological value and are fundamental to human well-being. The 52 Lebanese medicinal plants listed in this study could play a crucial role in the development of new, affordable, and effective ocular drugs. This study was the first on this topic and established a foundation for further phytochemical and pharmacological exploration.
However, significant research gaps were identified, particularly in the studies focusing on ocular medicinal plants and eye diseases. Notably, 33% of the studies involved in vivo or in vitro trials, indicating the need for more thorough investigations. While phytochemical products have shown promise as potential therapies, many remain untested or inadequately monitored. Additionally, the efficacy of herbal treatments can be highly variable due to differences in their sources, quality, combinations, and preparation methods. This lack of standardization may lead to potential adverse reactions. The safety of herbal medications remains a major concern, and regulatory bodies must ensure that all herbal medicines are safe and of acceptable quality [1].
Endemic plants, such as Crepis libanotica and Salvia libanotica, should be screened through standardized pharmacological and clinical procedures to assess their potential activities [7]. Consequently, research into the phytochemical profiles of these species, particularly those that are currently underexplored, can aid in discovering bioactive compounds with positive effects on ocular health while also uncovering the potential uses and economic importance of these plants.

Author Contributions

Conceptualization, J.A. and H.E.B.; Methodology, J.A.; Software, J.A.; Validation, J.A., R.A.-K. and H.E.B.; Formal Analysis, J.A.; Investigation, J.A.; Resources, J.A. and R.A.-K.; Data Curation, J.A. and R.A.-K.; Writing—Original Draft Preparation, J.A. and H.E.B.; Writing—Review and Editing, J.A. and H.E.B. Visualization, J.A.; Supervision, H.E.B.; Project Administration, R.A.-K. All authors have read and agreed to the published version of the manuscript.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Acknowledgments

The authors would like to thank the Holy Spirit University of Kaslik (USEK) and the American University of Science and Technology (AUST) for their assistance in the various steps leading to the submission of this work. We particularly thank the English and Research department of the Modern University for Business and Science (MUBS) for their proofreading and support.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

ACSAmerican Chemical Society
AMDAge-related macular degeneration
DMDiabetes mellitus
DRDiabetic retinopathy
EOsEssential oil
IOPInternal ocular pressure
MAPsMedicinal and aromatic plants
PSEDPosterior-segment eye disease
TFOS DEWS IITear Film and Ocular Surface Society Dry Eye Workshop II
VEGFVascular endothelial growth factor
TMTrabecular meshwork
UVUltraviolet radiation

References

  1. Ekor, M. The Growing Use of Herbal Medicines: Issues Relating to Adverse Reactions and Challenges in Monitoring Safety. Front. Pharmacol. 2014, 4, 177. [Google Scholar] [CrossRef]
  2. Pinheiro, G.K.L.d.O.; Araújo Filho, I.d.; Araújo Neto, I.d.; Rêgo, A.C.M.; de Azevedo, E.P. Nature as a Source of Drugs for Ophthalmology. Arq. Bras. Oftalmol. 2018, 81, 443–454. [Google Scholar] [CrossRef] [PubMed]
  3. Duncan, G.; Collison, D.J. Role of the Non-Neuronal Cholinergic System in the Eye. Life Sci. 2003, 72, 2013–2019. [Google Scholar] [CrossRef]
  4. Cowling, R.M.; Rundel, P.W.; Lamont, B.B.; Kalin Arroyo, M.; Arianoutsou, M. Plant Diversity in Mediterranean-Climate Regions. Trends Ecol. Evol. 1996, 11, 362–366. [Google Scholar] [CrossRef]
  5. Monari, S.; Ferri, M.; Salinitro, M.; Tassoni, A. Ethnobotanical Review and Dataset Compiling on Wild and Cultivated Plants Traditionally Used as Medicinal Remedies in Italy. Plants 2022, 11, 2041. [Google Scholar] [CrossRef] [PubMed]
  6. Pullaiah, T. (Ed.) Global Biodiversity: Selected Countries in Asia, 1st ed.; Apple Academic Press: New York, NY, USA, 2018; ISBN 978-0-429-48774-3. [Google Scholar]
  7. Baydoun, S.; Kanj, D.; Raafat, K.; Aboul Ela, M.; Chalak, L.; Arnold-Apostolides, N. Ethnobotanical and Economic Importance of Wild Plant Species of Jabal Moussa Bioreserve, Lebanon. J. Ecosyst. Ecogr. 2017, 7, 1000245. [Google Scholar] [CrossRef]
  8. Sangeetha, J.; Asokan, S. A Review on Traditional Medicine Used as Treatment for Conjunctivitis. J. Pharm. Drug Anal. 2018, 6, 191–196. [Google Scholar]
  9. Perez-Garmendia, R.; Rodriguez, A.L.d.E.; Ivan, R.-M.; Zuñiga, N.M.; Roberto, G.-S. Interplay between Oxidative Stress, Inflammation, and Amyloidosis in the Anterior Segment of the Eye; Its Pathological Implications. Oxidative Med. Cell. Longev. 2020, 2020, 6286105. [Google Scholar] [CrossRef] [PubMed]
  10. Bastawrous, A.; Burgess, P.I.; Mahdi, A.M.; Kyari, F.; Burton, M.J.; Kuper, H. Posterior Segment Eye Disease in Sub-S Aharan A Frica: Review of Recent Population-based Studies. Trop. Med. Int. Health 2014, 19, 600–609. [Google Scholar] [CrossRef]
  11. Committee on Public Health Approaches to Reduce Vision Impairment and Promote Eye Health; Board on Population Health and Public Health Practice; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine. Making Eye Health a Population Health Imperative: Vision for Tomorrow; Teutsch, S.M., McCoy, M.A., Woodbury, R.B., Welp, A., Eds.; National Academies Press: Washington, DC, USA, 2016; p. 23471. ISBN 978-0-309-43998-5. [Google Scholar]
  12. WHO. World Report on Vision; WHO: Geneva, Switzerland, 2019. [Google Scholar]
  13. BioRender. Available online: https://www.biorender.com/ (accessed on 10 October 2004).
  14. Sandhu, P.S.; Singh, B.; Gupta, V.; Bansal, P.; Kumar, D. Potential Herbs Used in Ocular Diseases. J. Pharm. Sci. 2011, 3, 1127. [Google Scholar]
  15. Teweldemedhin, M.; Gebreyesus, H.; Atsbaha, A.H.; Asgedom, S.W.; Saravanan, M. Bacterial Profile of Ocular Infections: A Systematic Review. BMC Ophthalmol. 2017, 17, 212. [Google Scholar] [CrossRef] [PubMed]
  16. Tewari, D.; Samoilă, O.; Gocan, D.; Mocan, A.; Moldovan, C. Medicinal Plants and Natural Products Used in Cataract Management. Front. Pharmacol. 2019, 10, 466. [Google Scholar] [CrossRef]
  17. Chu, K.-O.; Pang, C.-P. Herbal Molecules in Eye Diseases. Taiwan J. Ophthalmol. 2014, 4, 103–109. [Google Scholar] [CrossRef]
  18. Leonardi, A.; Motterle, L.; Bortolotti, M. Allergy and the Eye. Clin. Exp. Immunol. 2008, 153, 17–21. [Google Scholar] [CrossRef]
  19. Jones, L.; Downie, L.E.; Donald, K.; Benitez-del-Castillo, J.M.; Sophie, X.D. TFOS DEWS II Management and Therapy Report. Ocul. Surf. 2017, 15, 575–628. [Google Scholar] [CrossRef] [PubMed]
  20. Saccà, S.C. Oxidative DNA Damage in the Human Trabecular Meshwork: Clinical Correlation in Patients with Primary Open-Angle Glaucoma. Arch. Ophthalmol. 2005, 123, 458. [Google Scholar] [CrossRef]
  21. Wang, W.; Lo, A. Diabetic Retinopathy: Pathophysiology and Treatments. Int. J. Mol. Sci. 2018, 19, 1816. [Google Scholar] [CrossRef] [PubMed]
  22. Dimas, K.; Ulukaya, E.; Sakellaridis, N. Cancer of the Eye (Intraocular Cancer). In Reference Module in Biomedical Sciences; Elsevier: Amsterdam, The Netherlands, 2015; p. B978012801238399473X. ISBN 978-0-12-801238-3. [Google Scholar]
  23. Mouterde, P.; Charpin, A.; Greuter, W. Nouvelle Flore Du Liban et de La Syrie; Dar El-Machreq: Beyrouth, Lebanon, 1966. [Google Scholar]
  24. Choopani, R.; Saeed, S.; Kaveh, S.; Kaveh, N.; Dehghan, S. Pharmacological Treatment of Catarrh in Iranian Traditional Medicine. J. Tradit. Complement. Med. 2015, 5, 71–74. [Google Scholar] [CrossRef]
  25. Kianitalaei, A.; Feyzabadi, Z.; Hamedi, S.; Qaraaty, M. Althaea Officinalis in Traditional Medicine and Modern Phytotherapy. J Adv Pharm Edu Res 2019, 9, 154–161. [Google Scholar]
  26. Aslam, M.S.; Ahmad, M.S. Alhagi Maurorum and Tamarix Alphylla-Two Medicinal Weeds Mentioned in Holy Quran and Ahadith and Their Ethnomedicinal Uses in District Rajhanpur of Pakistan. Univers. J. Pharm. Res. 2016, 1, 80–84. [Google Scholar] [CrossRef]
  27. Raju, T.N.; Kanth, V.R.; Lavanya, K. Effect of Methanolic Extract of Allium Sativum (AS) in Delaying Cataract in STZ-Induced Diabetic Rats. J. Ocul. Biol. Dis. Inform. 2008, 1, 46. [Google Scholar] [CrossRef] [PubMed]
  28. Afarid, M.; Sadeghi, E.; Johari, M.; Namvar, E.; Sanie-Jahromi, F. Evaluation of the Effect of Garlic Tablet as a Complementary Treatment for Patients with Diabetic Retinopathy. J. Diabetes Res. 2022, 2022, 6620661. [Google Scholar] [CrossRef] [PubMed]
  29. Sheikh Saeed, A. Medicinal Wild Plant from Lahore-Islamabad Motorway (M-2). Pak. J. Bot. 2007, 39, 355–375. [Google Scholar]
  30. Tudor, C.; Pintea, A. A Brief Overview of Dietary Zeaxanthin Occurrence and Bioaccessibility. Molecules 2020, 25, 4067. [Google Scholar] [CrossRef]
  31. Xuan, T.D.; Khanh, T.D. Chemistry and Pharmacology of Bidens Pilosa: An Overview. J. Pharm. Investig. 2016, 46, 91–132. [Google Scholar] [CrossRef] [PubMed]
  32. Zhang, C.; Li, K.; Yang, Z.; Wang, Y.; Si, H. The Effect of the Aqueous Extract of Bidens Pilosa L. on Androgen Deficiency Dry Eye in Rats. Cell. Physiol. Biochem. 2016, 39, 266–277. [Google Scholar] [CrossRef]
  33. Tene, V.; Malagón, O.; Finzi, P.V.; Vidari, G.; Armijos, C.; Zaragoza, T. An Ethnobotanical Survey of Medicinal Plants Used in Loja and Zamora-Chinchipe, Ecuador. J. Ethnopharmacol. 2007, 111, 63–81. [Google Scholar] [CrossRef]
  34. Vahedian, Z.; Fang, L.; Fakhraie, G.; Amini, H.; Chiou, A.; Psychias, A.; Bovet, J.; Mozaffarieh, M. The Effect of Borage on Retinal Venous Pressure of Healthy Subjects with the Flammer Syndrome Running Title: Borage and Retinal Venous Pressure. JOJO 2017, 5, 555659. [Google Scholar] [CrossRef]
  35. Annaz, H.; Sane, Y.; Bitchagno, G.T.M.; Ben Bakrim, W.; Drissi, B. Caper (Capparis spinosa L.): An Updated Review on Its Phytochemistry, Nutritional Value, Traditional Uses, and Therapeutic Potential. Front. Pharmacol. 2022, 13, 878749. [Google Scholar] [CrossRef]
  36. Al-Snafi, A.E. The Pharmacological Importance Of Centaurea Cyanus—A Review. Pharm. Rev. Res. 2015, 5, 379–384. [Google Scholar]
  37. Ajayi, A.; Tanayen, J.; Magomere, A.; Ezeonwumelu, J. Antinociceptive and Anti-Inflammatory Effects of Aqueous Extract of Chenopodium Opulifolium Schrad Leaves. J. Intercult. Ethnopharmacol. 2017, 6, 14. [Google Scholar] [CrossRef] [PubMed]
  38. Janda, K.; Gutowska, I.; Geszke-Moritz, M.; Jakubczyk, K. The Common Cichory (Cichorium intybus L.) as a Source of Extracts with Health-Promoting Properties—A Review. Molecules 2021, 26, 1814. [Google Scholar] [CrossRef]
  39. Puhlmann, M.-L.; de Vos, W.M. Back to the Roots: Revisiting the Use of the Fiber-Rich Cichorium intybus L. Taproots. Adv. Nutr. 2020, 11, 878–890. [Google Scholar] [CrossRef] [PubMed]
  40. Pawar, R.D.; Thorat, K.B. Evaluation of Anticataract Activity of Citrullus colocynthis (L). Fruit Extract on Goat Lens. J. Emerg. Technol. Innov. Res. 2021, 8, b41–b52. [Google Scholar]
  41. Safaa, B.; Lamis, C.; Helena, D.; Nelly, A. Ethnopharmacological Survey of Medicinal Plants Used in Traditional Medicine by the Communities of Mount Hermon, Lebanon. J. Ethnopharmacol. 2015, 173, 139–156. [Google Scholar] [CrossRef]
  42. Balakrishnan, P.; Ajayan, S.; Mukkudakkattu, S.; Nechiyil, K.; Nambi, N. Review of Unique Ophthalmic Formulations in Vaidya Manorama: A Traditional Kerala Ayurveda Literature. J. Ayurveda Integr. Med. 2022, 13, 100576. [Google Scholar] [CrossRef]
  43. Kuete, V. Physical, Hematological, and Histopathological Signs of Toxicity Induced by African Medicinal Plants. In Toxicological Survey of African Medicinal Plants; Elsevier: Amsterdam, The Netherlands, 2014; pp. 635–657. ISBN 978-0-12-800018-2. [Google Scholar]
  44. Ahmad, T.; Cawood, M.; Iqbal, Q.; Ariño, A. Phytochemicals in Daucus Carota and Their Health Benefits—Review Article. Foods 2019, 8, 424. [Google Scholar] [CrossRef]
  45. Taiwo, E.A.; Abdulkareem, T.T.; Fajemisin, E. The Nutraceutical Potential of Carrots Carotenoids in Chronic Eyes Defects (CEDs): A Review. SSRN J. 2021. [Google Scholar] [CrossRef]
  46. Agarwal, R.; Gupta, S.K.; Srivastava, S.; Agrawal, S.S.; Saxena, R. Lowering of Intraocular Pressure by Topical Application of Daucus Carota Seed Extract in Rabbits. Indian J. Exp. Biol. 2008, 46, 541–546. [Google Scholar] [PubMed]
  47. European Medicines Agency. Assessment Report on Euphrasia officinalis L. and Euphrasia Rostkoviana Hayne, Herba, a Report of Committee on Herbal Medicinal Products; European Medicines Agency: London, UK, 2010. [Google Scholar]
  48. Bigagli, E.; Cinci, L.; D’Ambrosio, M.; Luceri, C. Pharmacological Activities of an Eye Drop Containing Matricaria Chamomilla and Euphrasia Officinalis Extracts in UVB-Induced Oxidative Stress and Inflammation of Human Corneal Cells. J. Photochem. Photobiol. B Biol. 2017, 173, 618–625. [Google Scholar] [CrossRef]
  49. Paduch, R.; Woźniak, A.; Niedziela, P.; Rejdak, R. Assessment of Eyebright (Euphrasia Officinalis L.) Extract Activity in Relation to Human Corneal Cells Using In Vitro Tests. Balk. Med. J. 2014, 33, 29–36. [Google Scholar] [CrossRef]
  50. Mohammad Sajjad, I.; Ali, A.; Seyed Hassan, T.; Alireza, S. The Curious Cases of Burn by Fig Tree Leaves. Indian J. Dermatol. 2019, 64, 71. [Google Scholar] [CrossRef]
  51. Pinto, A.R.; Machado Cunha, I.; Rebelo Gomes, E. Fig Tree-Induced Phytophotodermatitis: A Case Report on the Perils of a Hobby. Cureus 2023, 15, e41888. [Google Scholar] [CrossRef]
  52. Badgujar, S.B.; Patel, V.V.; Bandivdekar, A.H.; Mahajan, R.T. Traditional Uses, Phytochemistry and Pharmacology of Ficus carica: A Review. Pharm. Biol. 2014, 52, 1487–1503. [Google Scholar] [CrossRef]
  53. Agarwal, R.; Gupta, S.K.; Agrawal, S.S.; Srivastava, S.; Saxena, R. Oculohypotensive Effects of Foeniculum Vulgare in Experimental Models of Glaucoma. Indian J. Physiol. Pharmacol. 2008, 52, 77–83. [Google Scholar]
  54. Omar Adil, H.; Abu-Raghif, A.R.; Rasheed, A.M.; Al-Yawer, M.A. Effect of Foeniculum Vulgare Seed Aqueous Extract Eye Drops on Selenite Induced Cataract in Rabbits. Int. J. Pharm. Sci. Rev. Res 2007, 47, 83–87. [Google Scholar]
  55. Manzoor, A.R.; Bilal, A.D.; Shahnawaz, N.S.; Bilal, A.B.; Mushtaq, A.Q. Foeniculum Vulgare: A Comprehensive Review of Its Traditional Use, Phytochemistry, Pharmacology, and Safety. Arab. J. Chem. 2016, 9, S1574–S1583. [Google Scholar] [CrossRef]
  56. David, S.R. Fumaria Officinalis: Beggary, Common Fumitory, Earth Smoke [Fumaria officinalis L.]. In Materia Medica of New and Old Homeopathic Medicines; David, S.R., Ed.; Springer International Publishing: Cham, Switzerland, 2022; pp. 119–120. ISBN 978-3-030-65919-6. [Google Scholar]
  57. Küpeli Akkol, E.; Ilhan, M.; Kozan, E.; Gürağaç Dereli, F.T.; Sak, M.; Eduardo, S.-S. Insecticidal Activity of Hyoscyamus Niger L. on Lucilia Sericata Causing Myiasis. Plants 2020, 9, 655. [Google Scholar] [CrossRef] [PubMed]
  58. Alizadeh, A.; Moshiri, M.; Alizadeh, J.; Balali-Mood, M. Black Henbane and Its Toxicity—A Descriptive Review. Avicenna J. Phytomed 2014, 4, 297–311. [Google Scholar] [PubMed]
  59. Meher, S.; Ali, I.; Sami, A.; Ismail, M.; Naheed, N.; Khan, S.A. Screening of Some Medicinal Plants for Antibacterial Activity against Conjunctivitis. J. Anim. Plant Sci. 2017, 27, 2069–2074. [Google Scholar]
  60. Committee on Herbal Medicinal Products. Assessment Report on Linum usitatissimum L., Semen; 2015. Available online: https://www.ema.europa.eu/en/medicines/herbal/lini-semen (accessed on 10 October 2024).
  61. Pinheiro, M.N., Jr.; Santos, P.M.D.; Santos, R.C.R.D.; Barros, J.D.N.; Passos, L.F.; Cardoso Neto, J. Oral Flaxseed Oil (Linum usitatissimum) in the Treatment for Dry-Eye Sjögren’s Syndrome Patients. Arq. Bras. Oftalmol. 2007, 70, 649–655. [Google Scholar] [CrossRef] [PubMed]
  62. Renu, A.; Sk, G.; Sushma, S.; Rohit, S. IOP Lowering Effects of Ocimum Basilicum Seed Extract in Two Rabbit Models of Ocular Hypertension. J. Clin. Health Sci. 2019, 4, 39. [Google Scholar] [CrossRef]
  63. Ferreira, D.M.; de Oliveira, N.M.; Chéu, M.H.; Meireles, D.; Lopes, L.; Oliveira, M.B.; Machado, J. Updated Organic Composition and Potential Therapeutic Properties of Different Varieties of Olive Leaves from Olea Europaea. Plants 2023, 12, 688. [Google Scholar] [CrossRef]
  64. Hashmi, M.A.; Khan, A.; Hanif, M.; Farooq, U.; Perveen, S. Traditional Uses, Phytochemistry, and Pharmacology of Olea europaea (Olive). Evid.-Based Complement. Altern. Med. 2015, 2015, 541591. [Google Scholar] [CrossRef]
  65. Degerli, S.; Tepe, B.; Celiksoz, A.; Berk, S.; Malatyali, E. In Vitro Amoebicidal Activity of Origanum Syriacum and Origanum Laevigatum on Acanthamoeba Castellanii Cysts and Trophozoites. Exp. Parasitol. 2012, 131, 20–24. [Google Scholar] [CrossRef]
  66. Basile, A.A.; Mandelli, G.; Cendali, M.; Hufnagel, R. The Lubricating Effect of Eye Drops Containing Hyaluronic Acid and Mallow Extract in Patients with Dry Eye Disease—A Pilot Study. Medicina 2023, 59, 958. [Google Scholar] [CrossRef]
  67. El Mihyaoui, A.; Esteves da Silva, J.C.G.; Charfi, S.; Candela Castillo, M.E.; Lamarti, A.; Arnao, M.B. Chamomile (Matricaria chamomilla L.): A Review of Ethnomedicinal Use, Phytochemistry and Pharmacological Uses. Life 2022, 12, 479. [Google Scholar] [CrossRef]
  68. Lodhi, S.; Vadnere, G.; Sharma, V.; Usman, M. Marrubium Vulgare L.: A Review on Phytochemical and Pharmacological Aspects. J. Intercult. Ethnopharmacol. 2017, 6, 429. [Google Scholar] [CrossRef]
  69. Jeung, I.C.; Jee, D.; Rho, C.-R.; Kang, S. Melissa Officinalis L. Extracts Protect Human Retinal Pigment Epithelial Cells against Oxidative Stress-Induced Apoptosis. Int. J. Med. Sci. 2016, 13, 139–146. [Google Scholar] [CrossRef]
  70. Lee, E.K.; Kim, Y.J.; Kim, J.Y.; Song, H.B.; Yu, H.G. Melissa Officinalis Extract Inhibits Laser-Induced Choroidal Neovascularization in a Rat Model. PLoS ONE 2014, 9, e110109. [Google Scholar] [CrossRef]
  71. Eissa, T.A.F.; Palomino, O.M.; Carretero, M.E.; Gómez-Serranillos, M.P. Ethnopharmacological Study of Medicinal Plants Used in the Treatment of CNS Disorders in Sinai Peninsula, Egypt. J. Ethnopharmacol. 2014, 151, 317–332. [Google Scholar] [CrossRef]
  72. Amato, R.; Canovai, A.; Melecchi, A.; Maci, S.; Quintela, F.; Fonseca, B.A.; Cammalleri, M.; Dal Monte, M. Efficacy of a Spearmint (Mentha spicata L.) Extract as Nutritional Support in a Rat Model of Hypertensive Glaucoma. Trans. Vis. Sci. Technol. 2023, 12, 6. [Google Scholar] [CrossRef]
  73. Prashant, D.T.; Marybeth, K.F.; Sanjay, V.P.; Keith, H.B. Oleander-Associated Keratitis and Uveitis. Cornea 2022, 41, 1305–1307. [Google Scholar] [CrossRef]
  74. Najafian, Y.; Hamedi, S.S.; Kaboli Farshchi, M.; Feyzabadi, Z. Plantago Major in Traditional Persian Medicine and Modern Phytotherapy: A Narrative Review. Electron. Physician 2018, 10, 6390–6399. [Google Scholar] [CrossRef]
  75. EMA/HMPC/, 437859. Assessment Report on Plantago Lanceolata L., Folium; 2011. Available online: https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-plantago-lanceolata-l-folium_en.pdf (accessed on 10 October 2024).
  76. Iranshahy, M.; Javadi, B.; Iranshahi, M.; Jahanbakhsh, S.P.; Mahyari, S.; Hassani, F.V.; Karimi, G. A Review of Traditional Uses, Phytochemistry and Pharmacology of Portulaca oleracea L. J. Ethnopharmacol. 2017, 205, 158–172. [Google Scholar] [CrossRef]
  77. Mahboubi, M. Rosa Damascena as Holy Ancient Herb with Novel Applications. J. Tradit. Complement. Med. 2016, 6, 10–16. [Google Scholar] [CrossRef]
  78. Biswas, N.R.; Gupta, S.K.; Das, G.K.; Kumar, N.; Mongre, P.K.; Haldar, D.; Beri, S. Evaluation of Ophthacare Eye Drops a Herbal Formulation in the Management of Various Ophthalmic Disorders. Phytother. Res. 2001, 15, 618–620. [Google Scholar] [CrossRef]
  79. EMA/HMPC/137298/2013 Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on Rosa gallica L., Rosa centifolia L., Rosa damascena Mill., flos EMA/HMPC/137299/2013; 2013.
  80. Organisciak, D.T.; Darrow, R.M.; Rapp, C.M.; Smuts, J.P.; Armstrong, D.W.; Lang, J.C. Prevention of Retinal Light Damage by Zinc Oxide Combined with Rosemary Extract. Mol. Vis. 2013, 19, 1433–1445. [Google Scholar]
  81. Cannas, S.; Usai, D.; Pinna, A.; Benvenuti, S.; Roberta, T. Essential Oils in Ocular Pathology: An Experimental Study. J. Infect. Dev. Ctries 2015, 9, 650–654. [Google Scholar] [CrossRef] [PubMed]
  82. Homa, M.; Fekete, I.; Böszörményi, A.; Singh, Y.; Selvam, K. Antifungal Effect of Essential Oils against Fusarium Keratitis Isolates. Planta Med. 2015, 81, 1277–1284. [Google Scholar] [CrossRef]
  83. Gali-Muhtasib, H.; Hilan, C.; Khater, C. Traditional Uses of Salvia Libanotica (East Mediterranean Sage) and the Effects of Its Essential Oils. J. Ethnopharmacol. 2000, 71, 513–520. [Google Scholar] [CrossRef]
  84. Abu-Darwish, M.S.; Cabral, C.; Ferreira, I.V.; Gonçalves, M.J.; Cavaleiro, C. Essential Oil of Common Sage (Salvia officinalis L.) from Jordan: Assessment of Safety in Mammalian Cells and Its Antifungal and Anti-Inflammatory Potential. BioMed Res. Int. 2013, 2013, 538940. [Google Scholar] [CrossRef] [PubMed]
  85. Martínez-Francés, V.; Hahn, E.; Segundo, R.; Rivera, D.; Roser, V.; Cañigueral, S. Ethnopharmacological and Chemical Characterization of Salvia Species Used in Valencian Traditional Herbal Preparations. Front. Pharmacol. 2017, 8, 467. [Google Scholar] [CrossRef]
  86. Lin, C.; Li, C.; Liao, P.; Tse, L.; Huang, W.; Cheng, H.; Cheng, Y. Silibinin Inhibits VEGF Secretion and Age-Related Macular Degeneration in a Hypoxia-Dependent Manner through the PI-3 Kinase/Akt/mTOR Pathway: Silibinin Inhibits Retinal Neovascularization. Br. J. Pharmacol. 2013, 168, 920–931. [Google Scholar] [CrossRef] [PubMed]
  87. Cansever, E.; Turker, A.U. In Vitro Culture and Biological Activity of Solanum Dulcamara, a Medicinal Plant. Planta Med. 2007, 73, P_182. [Google Scholar] [CrossRef]
  88. Zahara, K.; Ahmad, N.; Bibi, Y.; Bibi, F.; Sadaf, H.M.; Sardar, N. An Insight to Therapeutic Potential and Phytochemical Profile of Solanum villosum (L). Med. Drug Discov. 2019, 2, 100007. [Google Scholar] [CrossRef]
  89. Egyptian Herbal Monograph; Ismail, S.I.; Abdel-Azim, D.N.S.; Shams, D.K.A.; Batanouny, K.H.; Batanouny, P.K.H. Uriginea maritima (L.), 195-200. EDA, Egypt. 2022. Available online: https://edaegypt.gov.eg/media/4h3gfxr5/urginea-maritima-l-baker-%D8%A8%D8%B5%D9%84-%D8%A7%D9%84%D8%B9%D9%86%D8%B5%D9%84.pdf (accessed on 10 October 2024).
  90. Fan, W.; Fan, L.; Peng, C.; Zhang, Q.; Wang, L. Traditional Uses, Botany, Phytochemistry, Pharmacology, Pharmacokinetics and Toxicology of Xanthium strumarium L.: A Review. Molecules 2019, 24, 359. [Google Scholar] [CrossRef] [PubMed]
  91. Hossain, M.A. A Phytopharmacological Review on the Omani Medicinal Plant: Ziziphus Jujube. J. King Saud Univ.-Sci. 2019, 31, 1352–1357. [Google Scholar] [CrossRef]
  92. Rojas-Sandoval, J. Ziziphus Spina-Christi (Christ’s Thorn Jujube). CABI Compend. 2017, 57569. [Google Scholar] [CrossRef]
  93. Ohia, S.E.; Opere, C.A.; LeDay, A.M. Pharmacological Consequences of Oxidative Stress in Ocular Tissues. Mutat. Res./Fundam. Mol. Mech. Mutagen. 2005, 579, 22–36. [Google Scholar] [CrossRef]
  94. Adelli, G.R. Phytochemicals in Ocular Health: Therapeutic Potential and Delivery Challenges. World J. Pharmacol. 2013, 2, 18. [Google Scholar] [CrossRef]
  95. Nadeem, M.S.; Kazmi, I.; Ullah, I.; Muhammad, K.; Anwar, F. Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment. Antioxidants 2021, 11, 87. [Google Scholar] [CrossRef]
  96. Borek, C. Antioxidant Health Effects of Aged Garlic Extract. J. Nutr. 2001, 131, 1010S–1015S. [Google Scholar] [CrossRef]
  97. Banerjee, S.K.; Maulik, S.K. Effect of Garlic on Cardiovascular Disorders: A Review. Nutr. J. 2002, 1, 4. [Google Scholar] [CrossRef] [PubMed]
  98. Arellano Buendía, A.S.; Tostado González, M.; Sánchez Reyes, O.; García Arroyo, F.E.; Argüello García, R.; Tapia, E.; Sánchez Lozada, L.G.; Osorio Alonso, H. Immunomodulatory Effects of the Nutraceutical Garlic Derivative Allicin in the Progression of Diabetic Nephropathy. Int. J. Mol. Sci. 2018, 19, 3107. [Google Scholar] [CrossRef] [PubMed]
  99. Song, X.; Yue, Z.; Nie, L.; Zhao, P.; Zhu, K.; Wang, Q. Biological Functions of Diallyl Disulfide, a Garlic-Derived Natural Organic Sulfur Compound. Evid. Based Complement. Altern. Med. 2021, 2021, 5103626. [Google Scholar] [CrossRef]
  100. Chai, G.-R.; Liu, S.; Yang, H.-W.; Chen, X.-L. Quercetin Protects against Diabetic Retinopathy in Rats by Inducing Heme Oxygenase-1 Expression. Neural Regen. Res. 2021, 16, 1344. [Google Scholar] [CrossRef] [PubMed]
  101. Stefek, M. Natural Flavonoids as Potential Multifunctional Agents in Prevention of Diabetic Cataract. Interdiscip. Toxicol. 2011, 4, 69–77. [Google Scholar] [CrossRef]
  102. Zhao, L.; Wang, H.; Du, X. The Therapeutic Use of Quercetin in Ophthalmology: Recent Applications. Biomed. Pharmacother. 2021, 137, 111371. [Google Scholar] [CrossRef]
  103. Kumar, S.; Kumar, D.; Jusha, M.; Saroha, K.; Singh, N.; Vashishta, B. Antioxidant and Free Radical Scavenging Potential of Citrullus colocynthis (L.) Schrad. Methanolic Fruit Extract. Acta Pharm. 2008, 58, 215–220. [Google Scholar] [CrossRef]
  104. Johra, F.T.; Bepari, A.K.; Bristy, A.T.; Reza, H.M. A Mechanistic Review of β-Carotene, Lutein, and Zeaxanthin in Eye Health and Disease. Antioxidants 2020, 9, 1046. [Google Scholar] [CrossRef]
  105. Benedec, D.; Oniga, I.; Hanganu, D.; Vlase, A.-M.; Ielciu, I.; Crișan, G.; Fiţ, N.; Niculae, M.; Bab, T.; Pall, E.; et al. Revealing the Phenolic Composition and the Antioxidant, Antimicrobial and Antiproliferative Activities of Two Euphrasia Sp. Extracts. Plants 2024, 13, 1790. [Google Scholar] [CrossRef]
  106. Badgujar, S.B.; Patel, V.V.; Bandivdekar, A.H. Foeniculum vulgare Mill: A Review of Its Botany, Phytochemistry, Pharmacology, Contemporary Application, and Toxicology. BioMed Res. Int. 2014, 2014, 842674. [Google Scholar] [CrossRef]
  107. Nafees, S.; Akhtar, J.; Kaur, J. Indian Traditional Medicinal Plants in Ophthalmic Diseases. Avicenna J. Phytomed. 2022, 12, 566–575. [Google Scholar] [CrossRef]
  108. Basgedik, B.; Ugur, A.; Sarac, N. Antimicrobial, Antioxidant, Antimutagenic Activities, and Phenolic Compounds of Iris Germanica. Ind. Crops Prod. 2014, 61, 526–530. [Google Scholar] [CrossRef]
  109. Kauser, S.; Hussain, A.; Ashraf, S.; Fatima, G.; Ambreen; Javaria, S.; Abideen, Z.U.; Kabir, K.; Yaqub, S.; Akram, S.; et al. Flaxseed (Linum usitatissimum); Phytochemistry, Pharmacological Characteristics and Functional Food Applications. Food Chem. Adv. 2024, 4, 100573. [Google Scholar] [CrossRef]
  110. Roncone, M.; Bartlett, H.; Eperjesi, F. Essential Fatty Acids for Dry Eye: A Review. Contact Lens Anterior Eye 2010, 33, 49–54. [Google Scholar] [CrossRef]
  111. Saccà, S.C.; Cutolo, C.A.; Ferrari, D.; Corazza, P.; Traverso, C.E. The Eye, Oxidative Damage and Polyunsaturated Fatty Acids. Nutrients 2018, 10, 668. [Google Scholar] [CrossRef] [PubMed]
  112. Barros, L.; Carvalho, A.M.; Ferreira, I.C.F.R. Leaves, Flowers, Immature Fruits and Leafy Flowered Stems of Malva Sylvestris: A Comparative Study of the Nutraceutical Potential and Composition. Food Chem. Toxicol. 2010, 48, 1466–1472. [Google Scholar] [CrossRef]
  113. Petrisor, G.; Motelica, L.; Craciun, L.N.; Oprea, O.C.; Ficai, D.; Ficai, A. Melissa Officinalis: Composition, Pharmacological Effects and Derived Release Systems—A Review. Int. J. Mol. Sci. 2022, 23, 3591. [Google Scholar] [CrossRef]
  114. Cui, H.; Zhang, X.; Zhou, H.; Zhao, C.; Lin, L. Antimicrobial Activity and Mechanisms of Salvia Sclarea Essential Oil. Bot. Stud. 2015, 56, 16. [Google Scholar] [CrossRef]
  115. Maaloul, S.; Ghzaiel, I.; Mahmoudi, M.; Mighri, H.; Pires, V.; Vejux, A.; Martine, L.; De Barros, J.-P.P.; Prost-Camus, E.; Boughalleb, F.; et al. Characterization of Silybum Marianum and Silybum Eburneum Seed Oils: Phytochemical Profiles and Antioxidant Properties Supporting Important Nutritional Interests. PLoS ONE 2024, 19, e0304021. [Google Scholar] [CrossRef]
  116. Fani, M.; Kohanteb, J. In Vitro Antimicrobial Activity of Thymus Vulgaris Essential Oil Against Major Oral Pathogens. J. Evid.Based Complement. Altern. Med. 2017, 22, 660–666. [Google Scholar] [CrossRef]
  117. Galovičová, L.; Borotová, P.; Valková, V.; Vukovic, N.L.; Vukic, M.; Štefániková, J.; Ďúranová, H.; Kowalczewski, P.Ł.; Čmiková, N.; Kačániová, M. Thymus Vulgaris Essential Oil and Its Biological Activity. Plants 2021, 10, 1959. [Google Scholar] [CrossRef] [PubMed]
  118. Carović-Stanko, K.; Petek, M.; Grdiša, M.; Pintar, J.; Bedeković, D.; Herak Ćustić, M. Medicinal Plants of the Family Lamiaceae as Functional Foods—A Review. Czech J. Food Sci. 2016, 34, 377–390. [Google Scholar] [CrossRef]
  119. Rolnik, A.; Olas, B. The Plants of the Asteraceae Family as Agents in the Protection of Human Health. Int. J. Mol. Sci. 2021, 22, 3009. [Google Scholar] [CrossRef] [PubMed]
  120. Alagar Yadav, S.; Koshi, F.S. Phytochemicals from Solanaceae Family and Their Anticancer Properties. In Medicinal Plants; Kumar, S., Ed.; IntechOpen: London, UK, 2022; ISBN 978-1-80356-032-8. [Google Scholar]
  121. Joo, J.-H. Effects and Pharmacological Use of Alkaloids on the Eyes. In Drug Repurposing—Advances, Scopes and Opportunities in Drug Discovery; Rudrapal, M., Ed.; IntechOpen: London, UK, 2023; ISBN 978-1-83768-776-3. [Google Scholar]
  122. Sharifi-Rad, J.; Melgar-Lalanne, G.; Hernández-Álvarez, A.J.; Taheri, Y.; Shabnum, S. Malva Species: Insights on Its Chemical Composition towards Pharmacological Applications. Phytother. Res. 2020, 34, 546–567. [Google Scholar] [CrossRef] [PubMed]
  123. Wang, Y.; Zhao, Y.; Liu, X.; Li, J.; Zhang, J.; Liu, D. Chemical Constituents and Pharmacological Activities of Medicinal Plants from Rosa Genus. Chin. Herb. Med. 2022, 14, 187–209. [Google Scholar] [CrossRef]
  124. Sakna, S.T.; Maghraby, Y.R.; Abdelfattah, M.S.; Farag, M.A. Phytochemical Diversity and Pharmacological Effects of Triterpenes from Genus Ziziphus: A Comprehensive Review. Phytochem. Rev. 2022, 22, 1611–1636. [Google Scholar] [CrossRef]
  125. El Beyrouthy, M.; Arnold, N.; Delelis-Dusollier, A.; Dupont, F. Plants Used as Remedies Antirheumatic and Antineuralgic in the Traditional Medicine of Lebanon. J. Ethnopharmacol. 2008, 120, 315–334. [Google Scholar] [CrossRef]
  126. Sultana, B.; Anwar, F.; Ashraf, M. Effect of Extraction Solvent/Technique on the Antioxidant Activity of Selected Medicinal Plant Extracts. Molecules 2009, 14, 2167–2180. [Google Scholar] [CrossRef]
  127. Pokkalath, A.S.; Sawant, A.; Sawarkar, S.P. Herbal Medicine for Ocular Diseases: An Age Old Therapy and Its Future Perspective. J. Drug Deliv. Sci. Technol. 2022, 68, 102979. [Google Scholar] [CrossRef]
  128. Ye, X.; Fung, N.S.K.; Lam, W.C.; Lo, A.C.Y. Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems. Nutrients 2024, 16, 1715. [Google Scholar] [CrossRef]
  129. Varela-Fernández, R.; Díaz-Tomé, V.; Luaces-Rodríguez, A.; Conde-Penedo, A.; García-Otero, X. Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations. Pharmaceutics 2020, 12, 269. [Google Scholar] [CrossRef]
  130. Diego, M. Use of Strawberry Tree (Arbutus Unedo) as a Source of Functional Fractions with Biological Activities. Foods 2022, 11, 3838. [Google Scholar] [CrossRef]
  131. Raúl, D.-P.; Lourdes, G.-G.; Dámaso, H.-M. Carotenoid Composition of Strawberry Tree (Arbutus unedo L.) Fruits. Food Chem. 2016, 199, 165–175. [Google Scholar] [CrossRef]
  132. Mariela, P.; Rubén, B.; José Luis, B.; Patricia, P. Allium Sativum Produces Terpenes with Fungistatic Properties in Response to Infection with Sclerotium Cepivorum. Phytochemistry 2015, 115, 152–160. [Google Scholar] [CrossRef]
  133. Omidi, M.; Khandan-Mirkohi, A.; Kafi, M.; Rasouli, O.; Shaghaghi, A.; Kiani, M.; Zamani, Z. Comparative Study of Phytochemical Profiles and Morphological Properties of Some Damask Roses from Iran. Chem. Biol. Technol. Agric. 2022, 9, 51. [Google Scholar] [CrossRef]
  134. Andrade, J.M.; Faustino, C.; Garcia, C.; Ladeiras, D.; Reis, C.P.; Rijo, P. Rosmarinus Officinalis L.: An Update Review of Its Phytochemistry and Biological Activity. Future Sci. OA 2018, 4, FSO283. [Google Scholar] [CrossRef] [PubMed]
  135. Agrahari, V.; Mandal, A.; Agrahari, V.; Trinh, H.M.; Joseph, M.; Ray, A.; Hadji, H.; Mitra, R.; Pal, D.; Mitra, A.K. A Comprehensive Insight on Ocular Pharmacokinetics. Drug Deliv. Transl. Res. 2016, 6, 735–754. [Google Scholar] [CrossRef]
  136. Pubchem—Recherche Google. Available online: https://pubchem.ncbi.nlm.nih.gov/ (accessed on 12 January 2025).
  137. Al-Ghadeer, H.; Al-Amry, M. Ocular Complications Resulting from the Use of Traditional Herbal Medicine in Central Saudi Arabia: A Review. Middle East Afr. J. Ophthalmol. 2021, 28, 131–136. [Google Scholar] [CrossRef] [PubMed]
  138. Miraldi, E.; Masti, A.; Ferri, S.; Barni Comparini, I. Distribution of Hyoscyamine and Scopolamine in Datura Stramonium. Fitoterapia 2001, 72, 644–648. [Google Scholar] [CrossRef] [PubMed]
  139. Zhai, J.; Dong, X.; Yan, F.; Guo, H.; Yang, J. Oleandrin: A Systematic Review of Its Natural Sources, Structural Properties, Detection Methods, Pharmacokinetics and Toxicology. Front. Pharmacol. 2022, 13, 822726. [Google Scholar] [CrossRef] [PubMed]
  140. Calf, O.W.; Huber, H.; Peters, J.L.; Weinhold, A.; Van Dam, N.M. Glycoalkaloid Composition Explains Variation in Slug Resistance in Solanum Dulcamara. Oecologia 2018, 187, 495–506. [Google Scholar] [CrossRef] [PubMed]
Figure 2. Flow chart of the study design.
Figure 2. Flow chart of the study design.
Pharmaceuticals 18 00155 g002
Figure 3. Percentages of article types used in the study.
Figure 3. Percentages of article types used in the study.
Pharmaceuticals 18 00155 g003
Figure 4. Percentage distribution of cited ocular medicinal plants.
Figure 4. Percentage distribution of cited ocular medicinal plants.
Pharmaceuticals 18 00155 g004
Figure 5. Percentage distribution of plant parts used to treat ocular diseases.
Figure 5. Percentage distribution of plant parts used to treat ocular diseases.
Pharmaceuticals 18 00155 g005
Figure 6. Percentage distribution of sites of action of medicinal plants.
Figure 6. Percentage distribution of sites of action of medicinal plants.
Pharmaceuticals 18 00155 g006
Table 1. Ocular medicinal plants found in the Lebanese flora.
Table 1. Ocular medicinal plants found in the Lebanese flora.
Scientific NameLocal NameFamilyPart UsedPreparationOcular TreatmentsCategoryType of ArticleReference
1Althaea officinalisEl KhaimahMalvaceaeFlowerNAEye inflammationAnterior partTraditional medicine [24]
Leaves Puffy and swollen eyelids Review[25]
Conjunctivitis
Eye discharge
Hordeolum
2Alhagi maurorumChawk El JamalPapilionaceae FlowerGround flowers powdered with sugarCleaning the eye Anterior partEthno-medicine[26]
Improving eyesight
3Allium sativumSin El ThoumLiliaceaeBulbMethanolic extractPreventing/delaying cataractsAnterior and posterior partResearch on the eye using in vivo study[27]
TabletDiabetic retinopathyResearch on the eye using in vivo study[28]
Lowering IOP
Improving visual acuity
Adjuvant treatment in diabetic macular edema
4Anagallis arvensisAin El JamalPrimulaceaeNAPlant juiceOphthalmia KertistisAnterior partLiterature survey and fieldwork[29]
Improving eyesight
5Arbutus unedoQuotlob EricaceaeFruitEdiblePreventing/delaying cataractsPosterior partReview (Zeaxanthin occurrence)[30]
Age-related macular degeneration
6Bidens pilosaHsseikiAsteraceaePlant juicePlant juiceEye irritationAnterior partReview[31]
Conjunctivitis
LeavesInfusionImproving aqueous tear quantityAnterior partResearch on the eye using in vivo study[32]
Maintaining tear film stability
Inhibiting the inflammation of the lacrimal gland
Maintaining tear film stability
7Borago officinalisLissan El ThawrBoraginaceaeLeavesInfusionConjunctivitisAnterior partEthnobotanical survey[33]
Flower
FlowerInfusionReduce retinal venous pressure Posterior partResearch on the eye using in vivo study[34]
8Capparis spinosaEl QuoubarCapparidaceaeLeavesInfusionEye infectionAnterior partReview[35]
BudOrally with a glass of water
9Centaurea cyanusEl QuantariounAsteraceaeFlowerEyewash with cornflowerEye inflammationAnterior partReview[36]
Infused blossomsConjunctivitis
Blepharitis
Relieve strained tired and puffy eyes
10Chenopodium opulifolium SarmoucChenopodiaceaeLeavesOintmentEye diseasesUnspecified eye diseasesResearch[37]
11Cichorioum intybusEl HindbehAsteraceaeFlowerInfusionEye inflammationAnterior partReview [38]
Periorbital puffiness
Symptoms of eye tiredness
Leaves External applicationEye infectionReview[39]
Root
Juice
12Citrullus colocynthisEl HanzalCucurbitaceaeFruitMethanolic extractsEye rednessAnterior partResearch on the eye using in vitro study[40]
Preventing/delaying cataracts
13Crepis robertioidesSaraghat
Robertieih
AsteraceaeFlowering partInfusionEye infectionAnterior partEthnopharmacological survey[41]
14Crepis libanoticaSaraghat
Lebnen
AsteraceaeFlowering partInfusionEye infectionAnterior partEthnopharmacological survey[41]
15Cyperus rotundusEl SaadCyperaceaeRhizomeDecoctionEye disease Review[14]
Ocular dischargesAnterior partReview[42]
16Datura stramoniumEl KhawkharaSolanaceaeSeedsExtractionMydriasis Toxicity Research[43]
Leaves SmokingPhotophobia
17Daucus carotaEl JazarUmbelliferae RootEdibleProtecting against chronic eye defects and vision lossAnterior partReview[44,45]
Protection against UVB
Improving eyesight
SeedsExtractionLower internal ocular pressure (IOP) Research on the eye using in vivo study[46]
18Euphrasia officinalisArkoun ToubiOrobanchaceaeWhole plantTincture
Extraction with ethanol
Herbal tea
ConjunctivitisAnterior partAssessment report[47]
Blepharitis
Eye fatigue
Ocular inflammation
Styes
Ocular allergies
Commercial eye drops Protecting corneal epithelial cells from UVB exposure Research on the eye using in vitro study[48]
Methanol and ethanol extractAnti-inflammatory
Reducing pro-inflammatory
cytokine expression
Research on the eye using in vitro study[49]
19Ficus caricaEl TinMoraceaeStemSap of the plantUsed in eye irritationToxicityCase study[50,51]
FruitEdible fruitImproving eyesight Anterior partReview[52]
Powder of dry fruits and sugar taken orally with water twice a day
20Foeniculum vulgareEl ChoumarApiaceaeSeedsWater seed extractReducing intraocular pressure (IOP)Anterior and posterior partResearch on the eye using in vivo study[53]
Anti-glaucoma
Protective and therapeutic effects against induced cataractsResearch on the eye using in vivo study[54]
Raw or with a sweetenerImproving eyesightReview[55]
21Fumaria officinalisBakleht
El Malak
PapaveraceaeStemEye lotionRed eye ToxicityBook chapter[56]
FlowerNAConjunctivitis
Heaviness in the eyes,
Stinging pain in the eyes
Swelling and puffiness of the eyes
Photophobia and tired eyes
22Hyoscyamus nigerEl Binij El AswadSolanaceaeSeedsExtractionInsecticidal activity (Lucilia sericata) Anterior partResearch [57]
Red eye
Itching in the eye
MydriasisToxicityReview[58]
Blurred vision
Photophobia
23Iris germanicaEl SawsanIridaceaeLeavesMethanol extractConjunctivitis Anterior partResearch on the eye using in vitro study[59]
Eye infection
24Juniperus excelsaEl CharbinCupressaceaeSeedsSeed extractEye diseasesUnspecified eye diseasesReview[14]
25Linum usitatissimumEl Kittein LinaceaeSeedsSeed mucilageRemoving foreign material from the eyeAnterior partAssessment report[60]
Eye irritation
Oral flaxseed oil capsulesDry-eye Sjögren’s syndrome patientsResearch on the eye using in vivo study[61]
26Ocimum basilicumEl RihanLamiaceaeSeeds Aqueous extractLower internal ocular pressure (IOP)Anterior partResearch on the eye using in vivo study[62]
27 El Zaytoun OleaceaeLeaves Infusions used as ointmentEye infectionsAnterior partResearch[63]
Management of dry-eye syndromeReview [64]
28Origanum syriacumZaatar souriLamiaceaeArial parts Methanol extractTreatment for amoebic keratitis Anterior partResearch[65]
29Origanum laevigatumMardakouchLamiaceaeArial parts Methanol extractTreatment for amoebic keratitis Anterior partResearch[65]
30Malvae sylvestrisKhibeiziMalvaceaeWhole plantMucilaginous extractDry-eye diseaseAnterior partResearch on the eye using in vivo study[66]
31Matricaria chamomilla AsteraceaeFlowerInfusion Protecting against UVB exposure Anterior partResearch on commercial eye drops (Dacriovis™)[48]
Leaves DecoctionEye irritation or eye infection Review[67]
Eyewash
Eye care
Swollen eyes
Tired eyes
Ameliorating wound healing
32Marrubium vulgareKourrat JabaliLamiaceaeLeaves ExtractionEye inflammationAnterior partReview[68]
Sore eyes
Leaf juice with honeyNight blindness
Clean eyesight
33Melissa officinalisEl MleissiLamiaceaeLeavesAqueous ethanol extractionDry age-related macular degeneration (AMD)Posterior partResearch on the eye using in vitro study[69]
Exudative AMDResearch[70]
34Mentha longifoliaAlnaenae al TawilLamiaceaeAerial part
Leaves
Infusion Eye diseasesAnterior partEthnopharmacological survey[71]
35Mentha spicataAlnaenae al AkhdarLamiaceaeExtract Marketed as NeumentixNutritional support in a rat model of hypertensive glaucomaPosterior partResearch on the eye using in vivo study[72]
36Nerium oleanderEl Delfi ApocynaceaeLeavesSap of the plantEye inflammation ToxicityCase study[73]
Light sensitivity
Keratitis and uveitis
Corneal edema
37Plantago lanceolataLissan El HamalPlantaginaceaeWhole plantLotion Eye illness wound repairAnterior partReport[74]
Leaves Ointment
Eye drops
Eye irritationReview [75]
Eye choroid diseases
Day blindness
Conjunctivitis
Eyes sores
38Portulaca oleraceaBakleh BarriehPortulacaceaeLeavesEdible plantInflammation of the eyesAnterior partReview[76]
SeedsDecoction
39Rosa damascenaWard DimachqyRosaceae Flower Rose waterEye washAnterior and posterior partReview[77]
Eye inflammationResearch on the eye using in vivo study on eye drop preparation (Ophthacare®) [78]
Degenerative ophthalmic disorders
40Rosa centifoliaWard OutriRosaceae FlowerInfusion Eye washAnterior partAssessment report[79]
Eye inflammation
41Rosemarinus officinalisEklil El JabalLamiaceaeWhole plantEssential oil Prevention of retinal light damageAnterior and posterior partResearch on the eye using in vivo study[80]
Antibacterial activityResearch on the eye using in vitro study[81]
Antimicrobial activity
42Salvia sclareaQaseinLamiaceaeLeavesEssential oil Antimicrobial activityAnterior partResearch on the eye using in vitro study[81]
Antifungal effect (fusarium keratitis)Research on the eye using in vitro study[82]
43Salvia Libanotica fruticosaMariamia
Loubnenieh
LamiaceaeLeavesInfusionEye inflammationAnterior partShort communication[83]
44Salvia officinalisQasein ToubiLamiaceaeArial parts Essential oilEye diseaseAnterior partResearch[84]
Arial parts Vapor inhalationOphthalmic anti-inflammatoryEthnopharmacological and chemical characterization [85]
Leaves NA
45Silybum marianumKharfeichAsteraceaeWhole plantIsolation of SilibininAge-related macular degenerationPosterior partResearch on the eye using in vitro study[86]
Neovascular AMD
46Solanum dulcamaraBathenjein
Aswad
SolanaceaeStemLipstickMydriasisToxicityCase report[87]
47Solanum villosumBathenjein
Ahmar
SolanaceaeWhole plantEdibleSore eyesAnterior partReview[88]
48Thymus vulgarisZaatar
Bari
LamiaceaeWhole plantEssential oil extraction
Steam distillation
Antimicrobial activityAnterior partResearch on the eye using in vitro study[81]
49Urginea maritimaBasal BariAsparagaceaeBulbFreshEye illnessUnspecified eye diseasesReport[89]
50Xanthium strumariumEl LizeiqAsteraceaeLeavesNAEye diseasesAnterior partReview[90]
SeedsImproving eyesight
51Ziziphus jujubaEl InabRhamnaceaeSeedsExtractionEye inflammationAnterior partReview[91]
52Ziziphus spina-christiEl SidirRhamnaceaeLeavesExtractionEye inflammationAnterior partReview[92]
NA (not available).
Table 2. Phytoconstituents and mechanisms of action of the listed medicinal plants (from research articles focused on the eyes).
Table 2. Phytoconstituents and mechanisms of action of the listed medicinal plants (from research articles focused on the eyes).
Plant SourceFamilyDisease or TargetPhytochemical(s)StructureMechanism of ActionReference
Allium sativumLiliaceaeCataractsAllicinPharmaceuticals 18 00155 i001Antioxidant activity prevents protein modifications in cataractous lenses[95]
S-allyl cysteinePharmaceuticals 18 00155 i002Antioxidant and anti-inflammatory properties
Protection against neurodegenerative diseases
[96]
Diabetic retinopathyS-allyl cysteineAn antidiabetic mechanism inhibits angiogenesis by downregulating vascular endothelial growth factor (VEGF) expression[97]
AllicinAllicin delays the progression of diabetic nephropathy through antioxidant and anti-inflammatory mechanisms[98]
Diallyl disulfide (DADS)Pharmaceuticals 18 00155 i003Anti-inflammatory and antioxidant mechanisms[99]
FlavonoidsPharmaceuticals 18 00155 i004Anti-oxidative, anti-inflammatory, and anti-apoptotic mechanisms
Inducing heme oxygenase-1 expression
[100]
Borago officinalisBoraginaceaeReducing retinal venous pressureGamma-linolenic acidPharmaceuticals 18 00155 i005Intermediate of PGE1, an endogenous vasodilator that enhances blood flow[34]
Phenolic CompoundsPharmaceuticals 18 00155 i006PhenolImproving blood flow
Citrullus colocynthisCucurbitaceaePreventing/delaying cataractsFlavonoids (Quercetin)Pharmaceuticals 18 00155 i007Oxidative stress leads to protein aggregation in the lens, which causes cataracts
Quercetin’s antioxidant activity can help protect lens proteins from oxidation
[101,102]
Phenolic compoundsPharmaceuticals 18 00155 i008PhenolAntioxidant and free radical scavenging[103]
Daucus carotaUmbelliferaeProtecting against chronic defects and vision lossCarotenoids (beta-carotene, lutein, and zeaxanthin)Pharmaceuticals 18 00155 i009Beta-carotene
Pharmaceuticals 18 00155 i010Lutein
Protecting the eye from oxidative stress, apoptosis, mitochondrial dysfunction, and inflammation[104]
Euphrasia officinalisOrobanchaceaeProtecting corneal epithelial cells against UVB exposure
Anti-inflammatory effects
Phenolic compounds
gentisic, caftaric, vanillic and rosmarinic acid,
hyperoside (quercetin-3-O-galactoside), and quercitrin (quercetin 3-O-rhamnoside)
Pharmaceuticals 18 00155 i011Vanillic acid
Pharmaceuticals 18 00155 i012Gentisic acid
Pharmaceuticals 18 00155 i013Quercetin-3-O-galactoside
Pharmaceuticals 18 00155 i014Quercetin 3-O-rhamnoside
Antioxidant, antimicrobial and antiproliferative activities[105]
Foeniculum vulgareApiaceaeReducing intraocular pressure (IOP)NA Anticholinesterase activity, which may help lower IOP[53]
Protective and therapeutic effects against induced cataractsAnethole
Fenchone
Flavonoids
Pharmaceuticals 18 00155 i015Anethole
Pharmaceuticals 18 00155 i016Fenchone
Inhibiting oxidative stress and preventing lens opacity
Antioxidant and anti-inflammatory activities
[54,106,107]
Iris germanicaIridaceaEye infectionPhenolic compounds:
Protocatechuic acid, Catechin,
p-Hydroxy benzoic acid, and caffeic and Ferulic acid
Pharmaceuticals 18 00155 i017Protocatechuic acid
Pharmaceuticals 18 00155 i018Catechin
Pharmaceuticals 18 00155 i019p-HydroxyBenzoicacid
Pharmaceuticals 18 00155 i020Caffeic acid
Pharmaceuticals 18 00155 i021Ferulic acid
Antimicrobial, antioxidant, and antimutagenic activities[108]
Linum usitatissimumLinaceaeDry-eye Sjögren’s syndrome patientsEssential fatty acids (EFAs), particularly omega-3Pharmaceuticals 18 00155 i022α-linolenic acidImproving tear production and reducing inflammation[109,110]
Ocimum basilicumLamiaceaeLower internal ocular pressure (IOP)Unsaturated fatty acids including α-linolenic, linoleic, and oleic acids
Saturated fatty acids (palmitic and stearic acid)
Pharmaceuticals 18 00155 i023Palmitic acid
Pharmaceuticals 18 00155 i024Stearic acid
Pharmaceuticals 18 00155 i025Oleic acid
Pharmaceuticals 18 00155 i026Linoleic acid
Pharmaceuticals 18 00155 i027α-linolenic acid
Anti-inflammatory effects
Reduction in aqueous humor production
[111]
Malvae sylvestrisMalvaceaeDry-eye diseasePlant mucus Mucilaginous substances have the potential to support the lubricating effect[66,112]
Phenols, flavonoids, carotenoids, unsaturated fatty acidsSee above structuresAntioxidants
Melissa officinalisLamiaceaeAge-related macular degeneration (AMD)Volatile compounds (geranial, neral, citronellal, and geraniol)
Phenolic acids (rosmarinic and caffeic acid)
Flavonoids (quercetin, rhamnocitrin, and luteolin)
Pharmaceuticals 18 00155 i028 Geranial
Pharmaceuticals 18 00155 i029 Citronellal
Pharmaceuticals 18 00155 i030 Geraniol
Reducing apoptosis and oxidative damage
Potent antioxidant properties and ability to act as a radical scavenger
[69,113]
Mentha spicataLamiaceaeGlaucomaPhenolic compounds Improving levels of neurotrophins, along with reducing oxidative stress and inflammation markers[72]
Rosemarinus officinalisLamiaceaePrevention of retinal light damage
Antibacterial activity
Essential oil components including monoterpene, diterpene, and sesquiterpene hydrocarbons, azulene, alcohols, aldehydes, and ketonesPharmaceuticals 18 00155 i031Monoterpene myrcene
Pharmaceuticals 18 00155 i032 Diterpene retiol
Pharmaceuticals 18 00155 i033 Azulene
Antimicrobial activity of EO[80,81]
Carnosol, carnosic, rosmanol, rosmarinic and ursolic acidPharmaceuticals 18 00155 i034Carnosol
Pharmaceuticals 18 00155 i035Carnosic acid
Antioxidants
Salvia sclareaLamiaceaeAntimicrobial and antifungal effectsEssential oil components include monoterpene, diterpene, and sesquiterpene hydrocarbons and azulene,See above structuresAntimicrobial activity of EO[81,114]
Silybum marianumAsteraceaeAge-related macular degenerationFlavonolignans, silymarin
(silybin, isosilybin, silychristin, dihydrosilybin, and silydrianin)
Pharmaceuticals 18 00155 i036silybin
Pharmaceuticals 18 00155 i037 Isosilybin
Antioxidant properties[86,115]
Thymus vulgarisLamiaceaeAntimicrobial activityEssential oil components including monoterpene, diterpene, and sesquiterpene hydrocarbons, azulene, alcohols, aldehydes, ketones, α-thujene, α-pinene, and camphenePharmaceuticals 18 00155 i038 α-thujene
Pharmaceuticals 18 00155 i039 α-pinene
Pharmaceuticals 18 00155 i040 Camphene
Antimicrobial activity of EO[81,116,117]
Table 3. Main phytochemical components of some listed Lebanese medicinal plants acting on the anterior and posterior eye segment simultaneously. Properties were retrieved from PubChem [136].
Table 3. Main phytochemical components of some listed Lebanese medicinal plants acting on the anterior and posterior eye segment simultaneously. Properties were retrieved from PubChem [136].
Medicinal Plant CompoundSolubilityMolecular Weight (Daltons)Functional GroupsPubchem CID
Allium sativum [132]

Pharmaceuticals 18 00155 i041
AllicinSoluble in alcohol and organic solvents; sparingly soluble in water162.19 Thioester, alkene (C=C), eherCID: 6391
AllinSoluble in water and organic solvents177.21 Sulfide, amineCID: 6320
E-AjoeneSoluble in alcohol and organic solvents, low solubility in water206.33 Disulfide, alkene (C=C)CID: 10632
Foeniculum vulgare [55]

Pharmaceuticals 18 00155 i042
Trans-AnetholeSoluble in alcohol and lipids, sparingly soluble in water148.21 Ether (-OCH₃), vinyl group (C=C)CID: 10203
FenchoneSoluble in organic solvents, practically insoluble in water150.22 Ketone (C=O)CID: 6395
EstragoleSoluble in organic solvents, low solubility in water148.21 Ether (-OCH₃), alkene (C=C)CID: 9887
Rosa damascene [133]

Pharmaceuticals 18 00155 i043
Nonadecane Insoluble in water but soluble in organic solvents270.45 Alkane CID: 6295
GeraniolSoluble in alcohol and lipids, low solubility in water154.25 Alcohol (-OH), alkene (C=C)CID: 10445
CitronellolSoluble in alcohol and oils, low solubility in water154.25 Alcohol (-OH), alkene (C=C)CID: 10242
Rosemarinus officinalis [134]

Pharmaceuticals 18 00155 i044
Carnosic AcidSoluble in organic solvents, insoluble in water330.46 Carboxylic acid (-COOH)CID: 5281642
CarnosolSoluble in organic solvents, insoluble in water316.45 Alcohol (-OH), ketone (C=O)CID: 5281643
Rosmarinic AcidSoluble in water and organic solvents360.36 Ester, carboxylic acid (-COOH)CID: 442800
Table 4. Phytoconstituents and mechanisms of action of toxic medicinal plants.
Table 4. Phytoconstituents and mechanisms of action of toxic medicinal plants.
Plant Source Disease Phytochemical(s)Mechanism of ActionReference
Datura stramonium
Pharmaceuticals 18 00155 i045
Mydriasis, photophobiaAlkaloids: atropine, scopolamine, and hyoscyamineAlkaloids work by blocking the muscarinic acetylcholine receptors in the iris sphincter muscle, which results in prolonged pupil dilation[43,138]
Ficus carica
Pharmaceuticals 18 00155 i046
Eye irritationFurocoumarins: psoralen and bergapten. Can cause skin and eye irritation
Photosensitizing properties, which can lead to photodermatitis
[51]
Hyoscyamus niger
Pharmaceuticals 18 00155 i047
Red eye
Mydriasis
Alkaloids, primarily hyoscyamine, atropine, and scopolamineAnticholinergic activities[43,138]
Nerium oleander
Pharmaceuticals 18 00155 i048
Eye inflammation, Light sensitivity, keratitis, and uveitis Corneal edemaCardiac glycosides
oleandrin, nerin, and digitoxigenin
Can irritate skin and mucous membranes, including the eyes[73,139]
Solanum dulcamara
Pharmaceuticals 18 00155 i049
MydriasisTropane alkaloids, such as solanine and other glycoalkaloidsAnticholinergics can cause pupil dilation by blocking the action of acetylcholine[140]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Andary, J.; El Ballouz, H.; Abou-Khalil, R. Lebanese Medicinal Plants with Ophthalmic Properties. Pharmaceuticals 2025, 18, 155. https://doi.org/10.3390/ph18020155

AMA Style

Andary J, El Ballouz H, Abou-Khalil R. Lebanese Medicinal Plants with Ophthalmic Properties. Pharmaceuticals. 2025; 18(2):155. https://doi.org/10.3390/ph18020155

Chicago/Turabian Style

Andary, Jeanne, Haitham El Ballouz, and Rony Abou-Khalil. 2025. "Lebanese Medicinal Plants with Ophthalmic Properties" Pharmaceuticals 18, no. 2: 155. https://doi.org/10.3390/ph18020155

APA Style

Andary, J., El Ballouz, H., & Abou-Khalil, R. (2025). Lebanese Medicinal Plants with Ophthalmic Properties. Pharmaceuticals, 18(2), 155. https://doi.org/10.3390/ph18020155

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop